Related Experiment Videos
Melatonin: therapeutic use in sleep disorders
The Annals of Pharmacotherapy
|October 24, 1997
Summary
Melatonin may offer modest benefits for sleep disorders like insomnia and jet lag, particularly in neurologically impaired individuals. However, more research is needed on its long-term efficacy and safety.
Area of Science:
- Sleep Medicine
- Chronobiology
- Pharmacology
Background:
- Melatonin is a hormone intrinsically linked to human circadian sleep-wake cycles.
- Reduced endogenous melatonin or disrupted circadian rhythms (e.g., aging, jet lag, shift work) may impair sleep.
- Exogenous melatonin supplementation is explored for sleep disorder management.
Purpose of the Study:
- To review the existing literature on melatonin's efficacy in various sleep disorders.
- To assess its use in jet lag, shift work disorder, insomnia, and in neurologically impaired patients.
- To identify gaps in current research regarding melatonin's therapeutic applications.
Main Methods:
- Comprehensive MEDLINE search (1966-1996) for clinical studies and reviews on melatonin.
- Screening of references from identified articles for additional relevant information.
- Inclusion of all published trials, with emphasis on recent studies (last 5 years).
Main Results:
- Melatonin shows potential for improving sleep duration and quality in disrupted circadian cycles.
- Evidence suggests efficacy in reducing jet lag symptoms and aiding shift workers' sleep.
- Some data indicate melatonin may help induce sleep onset in certain insomnia cases.
Conclusions:
- Melatonin may possess modest efficacy for insomnia, jet lag, and sleep issues in neurologically impaired patients.
- Adequate long-term studies on melatonin's efficacy and toxicity are currently lacking.
- Further research is warranted to establish optimal dosages, timing, and potential drug interactions.